The Treatment and Management of Type 1 Diabetes Mellitus - New Insulins and Delivery Systems

This month, Sheryl Merkin, M.S., F.N.P., C.D.E., Sharon Movsas, M.S., R.D., C.D.E. and Joel Zonszein, M.D., C.D.E., discuss

CME credit is no longer available for this conference.

Sheryl Merkin, M.S., F.N.P., C.D.E., Sharon Movsas, M.S., R.D., C.D.E. and Joel Zonszein, M.D., C.D.E.

Release Date: 07/24/2006

Upon completion of this Cyberounds^®, you should be able to:

State the recommendations for glucose monitoring and diet in individuals receiving intensive insulin therapy
Explain the basic principles of insulin replacement hormone utilizing basal/bolus regimens
Identify the new insulins and new insulin delivery systems.

The Treatment and Management of Type 1 Diabetes Mellitus: 2019 Update

New and modified treatment options for the TIDM patient.

Authors: Sheryl Merkin, M.S., F.N.P., C.D.E., Sharon Movsas, M.S., R.D., C.D.E. and Joel Zonszein, M.D., C.D.E.

View Course

Acromegaly is a clinical syndrome occurring as a consequence of growth hormone excess during adult life, most often from a pituitary adenoma.

Authors: Nicholas A. Tritos, M.D., D.Sc.

View Course

Progestin therapy affects every major organ system including the brain.

Authors: Muye Zhu, B.S., and Roberta Diaz Brinton, Ph.D.

View Course

The brain is an exceptionally lipid-rich organ.

Authors: Simona Vuletic, M.D.

View Course

The complications of diabetes mellitus that affect the nervous system belong to the category of metabolic neuropathies.

Authors: John W. Wiley, M.D., and Roberto Towns, Ph.D.

View Course

The brain is an obligate glucose consumer and critically dependent on glucose supply for normal function.

Authors: Kelly A. Diggs-Andrews, B.S., Julie M. Silverstein, M.D., and Simon J. Fisher, M.D., Ph.D.

View Course